Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta
NACompletedINTERVENTIONAL
Enrollment
100
Participants
Timeline
Start Date
April 1, 2020
Primary Completion Date
May 15, 2021
Study Completion Date
May 30, 2021
Conditions
Covid19 Positive Patients
Interventions
DIAGNOSTIC_TEST
Interlukein 6 and procalcitonin serum levels
Blood tests
Trial Locations (1)
1234
Cmh Quetta, Quetta
All Listed Sponsors
lead
FARAH AFZAL
OTHER
NCT04945811 - Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta | Biotech Hunter | Biotech Hunter